Justin M. Hall
Latest Articles
Bank Of America Well Positioned For A Big Move (Follow-Up)
Bank Of America Potentially Setting Up For Big Move
New Kids' Tablet Should Help LeapFrog Jump Higher
The Big Move: The End Of The 2011 Corn Bubble Nears
The Big Move (Part 3): The 2011 Corn Bubble Will Burst
The Big Move (Part 2): Playing The Corn Bubble With These 2 ETFs
The Big Move (Part 1): The Corn Correction Of 2011
Strategies for Pending Biotech Correction
Biotech Stock ETF Due for a Correction
Teva Positioned to Acquire Spectrum Pharmaceuticals?
Look for Spectrum Pharmaceuticals to Rebound Short-Term
Teva Positioned to Acquire Spectrum Pharmaceuticals After Fusilev Approval
Spectrum Pharmaceuticals Set to Beat Analyst Estimates Today
FDA Likely to Approve Spectrum Pharma's Cancer Drug After Second Look
Spectrum Pharma: Zevalin Has Blockbuster Potential 2.0
Optimistic About Endologix Following Nellix Acquisition
EpiCept's Promising Leukemia Drug: A Buying Opportunity?
Spectrum Pharmaceuticals: Packed With Opportunities
Three Promising Small-Cap Cancer Plays
Anika: A Hidden Biotech Buy
Spectrum Pharmaceuticals: Looking Ahead at Continued Growth
Infinity Pharmaceuticals: A Promising, Underappreciated Cancer Drug Maker
Three Underappreciated Cancer Drug Makers
Spectrum Pharma: Additional Trial Not Required
December's Game Plan for Biotech
Spectrum Pharma: Zevalin Sales Ramp Up
Spectrum Pharma: CMS Rules in Favor of Zevalin
Spectrum Pharma: Zevalin Has Blockbuster Potential
On Small Cap Drug Makers and Volatility
Spectrum Pharmaceuticals: Undervalued and (Now) Oversold
How Zevalin Is Helping Spectrum
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers